ARTICLE | Clinical News
Glybera regulatory update
December 6, 2010 8:00 AM UTC
Amsterdam Molecular submitted responses to Day 120 questions from the European Medicines Agency (EMA) related to the review of an MAA for Glybera to treat lipoprotein lipase (LPL) deficiency. The com...